PRJNA765501
Neuroblastoma cell line LAN-5 whole-exome sequencing
The neuroblastoma cell line LAN-5 was analysed using whole-exome sequencing for mutations in the RAS/MAPK pathway and ALK downstream signalling in general before introduction of perturbations. WES was performed to be sure the observed phenotypic response results from the specific perturbation only.